Synergistic Anticancer Effects of Lenvatinib and Celastrol via Reactive Oxygen Species–Mediated Endoplasmic Reticulum Stress and JNK Signaling in Colon Cancer Cells
Cancer Research and Treatment · 2026
DOI: 10.4143/crt.2025.508 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Research and Treatment, 2026. Verfasst von Ying Yan und 11 weiteren Autor:innen. Beteiligte Einrichtung: Affiliated Yueqing Hospital, Wenzhou Medical University, Zhejiang, China. Hauptthemen laut MEDLINE: Reactive Oxygen Species, Endoplasmic Reticulum Stress, Pentacyclic Triterpenes, Colonic Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Zhejiang Provincial Natural Science Foundation.
Abstract (Originalsprache)
Purpose
Colon cancer, a predominant contributor to global cancer mortality, is characterized by uncontrolled cell growth in the colon or rectum. Therapeutic progress notwithstanding, including targeted therapies and chemotherapy, the survival rate remains unsatisfactory, especially for patients with advanced colon cancer, underscoring the need for novel strategies to enhance treatment efficacy.Materials and Methods In this study, we employed Western blot analysis to quantify target protein expression levels and immunofluorescence for protein detection and localization. To evaluate drug interactions, we calculated the Combination Index. Intracellular reactive oxygen species (ROS) levels were measured using the DCFH-DA probe. Additionally, we generated target gene-knockdown cell lines via recombinant lentivirus transfection. For in vivo validation, we established a xenograft tumor model in nude mice to assess the therapeutic efficacy of the drug combination.
Results
In the study, we systematically evaluated the combinatorial potential of clinically approved lenvatinib and bioactive celastrol against colorectal cancer pathogenesis. Our results demonstrated that the combination treatment significantly inhibited cancer cell proliferation by enhancing ROS generation. This oxidative stress activated the ATF4-CHOP and JNK signaling pathways, ultimately inducing cell apoptosis as the main cause of death phenomenon.
Conclusion
Our research demonstrates that celastrol potentiates lenvatinib’s anti-tumor effects in colon cancer by inducing ROS-dependent endoplasmic reticulum stress and triggering phosphorylation-dependent JNK pathway activation. These findings reveal a promising combinatorial strategy to enhance therapeutic efficacy in colorectal carcinoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Affiliated Yueqing Hospital, Wenzhou Medical University, Zhejiang, China.
- School of Pharmaceutical Sciences, Wenzhou Medical University, Zhejiang, China.
- The First Affiliated Hospital of Wenzhou Medical University, Wenzhou Medical University, Zhejiang, China.
- Affiliated Yueqing Hospital, Wenzhou Medical University, Zhejiang, China. zoupeng@wmu.edu.cn.
- School of Pharmaceutical Sciences, Wenzhou Medical University, Zhejiang, China. zoupeng@wmu.edu.cn.
- Affiliated Yueqing Hospital, Wenzhou Medical University, Zhejiang, China. daoyongni@163.com.
Förderung
- Zhejiang Provincial Natural Science Foundation
Zitieren
APA
Yan, Y., Qiu, C., Fu, W., Shu, C., Xu, C., Chen, Y., Xia, Y., Chen, J., Chen, Y., Cui, R., Zou, P., & Ni, D. (2026). Synergistic Anticancer Effects of Lenvatinib and Celastrol via Reactive Oxygen Species–Mediated Endoplasmic Reticulum Stress and JNK Signaling in Colon Cancer Cells. Cancer Research and Treatment. https://doi.org/10.4143/crt.2025.508
Vancouver
Yan Y, Qiu C, Fu W, Shu C, Xu C, Chen Y, et al. Synergistic Anticancer Effects of Lenvatinib and Celastrol via Reactive Oxygen Species–Mediated Endoplasmic Reticulum Stress and JNK Signaling in Colon Cancer Cells. Cancer Research and Treatment. 2026. doi:10.4143/crt.2025.508
BibTeX
@article{Yan2026,
author = {Yan, Ying and Qiu, Chenyu and Fu, Wenying and Shu, Chongchong and Xu, Chenxin and Chen, Yinghua and Xia, Yiqun and Chen, Jundixia and Chen, Yunzhi and Cui, Ri and Zou, Peng and Ni, Daoyong},
title = {Synergistic Anticancer Effects of Lenvatinib and Celastrol via Reactive Oxygen Species–Mediated Endoplasmic Reticulum Stress and JNK Signaling in Colon Cancer Cells},
journal = {Cancer Research and Treatment},
year = {2026},
doi = {10.4143/crt.2025.508}
}
EUVIMED